Publication number: 20240299333
Abstract: A ((((1r,3R,5S,7r)-3,5-dimethyladamantan-1-yl)carbamoyl)oxy)-methyl benzoate injection preparation contains ((((1r,3R,5S,7r)-3,5-dimethyladamantan-1-yl)carbamoyl)oxy)-methyl benzoate, a suspension agent, a stabilizer, an osmotic pressure adjustment agent, a pH regulator and a solvent; and the preparation may be a ready-to-use liquid injection and may also be a lyophilized powder for injection. The preparation has noticeable slow-release effects after injection, so that the drug action time can be prolonged, the frequency of dose can be reduced, the compliance of patients can be enhanced, and bioavailability can be increased. A method for preparing the above-mentioned ((((1r,3R,5S,7r)-3,5-dimethyladamantan-1-yl)carbamoyl)oxy)-methyl benzoate injection preparation is simple, economical and suitable for industrial production.
Type:
Application
Filed:
October 14, 2020
Publication date:
September 12, 2024
Applicant:
SUNSHINE LAKE PHARMA CO., LTD.
Inventors:
Binbin GUO, Juan LI, Ping SONG, Jiajun GUO, Liuxiao TU, Fayin TIAN, Buwen ZHAO, Jinsong YOU, Fangfang HUANG